Immunoassay Systems - Global Strategic Business Report

The global market for Immunoassay Systems is estimated at US$23.2 Billion in 2023 and is projected to reach US$29.9 Billion by 2030, growing at a CAGR of 3.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Additionally, customization, flexibility, and a focus on precision medicine are driving the demand for immunoassay systems tailored to specific laboratory needs. Multiplexed immunoassays, allowing simultaneous measurement of multiple analytes, are gaining popularity for their comprehensive analysis of biological samples. . Immunoassay systems are vital for identifying biomarkers and specific disease states, thus supporting personalized treatment plans. Laboratories are increasingly looking for immunoassay systems that can be customized to their specific needs. Systems that offer flexibility in terms of scalable throughput, open reagent systems, and a broad menu of tests are particularly appealing. Moreover, sustainability and eco-friendliness are becoming key considerations in system design, with manufacturers focusing on reducing energy consumption and waste production, aligning with global sustainability goals.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Immunoassay Reagents & Kits segment, which is expected to reach US$19.4 Billion by 2030 with a CAGR of a 3.6%. The Immunoassay Analyzers / Instruments segment is also set to grow at 2.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $6.3 Billion in 2023, and China, forecasted to grow at an impressive 6.4% CAGR to reach $6.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Immunoassay Systems Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Immunoassay Systems Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Immunoassay Systems Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Laboratories, Beckman Coulter Inc., bioMérieux SA, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 29 Featured):

• Abbott Laboratories
• Beckman Coulter Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A
• Ortho-Clinical Diagnostics Inc.
• Quidel Corporation
• Roche Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Tosoh Bioscience Inc.